Literature DB >> 19543283

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Nicolas Chomont1, Mohamed El-Far, Petronela Ancuta, Lydie Trautmann, Francesco A Procopio, Bader Yassine-Diab, Geneviève Boucher, Mohamed-Rachid Boulassel, Georges Ghattas, Jason M Brenchley, Timothy W Schacker, Brenna J Hill, Daniel C Douek, Jean-Pierre Routy, Elias K Haddad, Rafick-Pierre Sékaly.   

Abstract

HIV persists in a reservoir of latently infected CD4(+) T cells in individuals treated with highly active antiretroviral therapy (HAART). Here we identify central memory (T(CM)) and transitional memory (T(TM)) CD4(+) T cells as the major cellular reservoirs for HIV and find that viral persistence is ensured by two different mechanisms. HIV primarily persists in T(CM) cells in subjects showing reconstitution of the CD4(+) compartment upon HAART. This reservoir is maintained through T cell survival and low-level antigen-driven proliferation and is slowly depleted with time. In contrast, proviral DNA is preferentially detected in T(TM) cells from aviremic individuals with low CD4(+) counts and higher amounts of interleukin-7-mediated homeostatic proliferation, a mechanism that ensures the persistence of these cells. Our results suggest that viral eradication might be achieved through the combined use of strategic interventions targeting viral replication and, as in cancer, drugs that interfere with the self renewal and persistence of proliferating memory T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19543283      PMCID: PMC2859814          DOI: 10.1038/nm.1972

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  51 in total

1.  Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAART.

Authors:  Helene Mens; Anders G Pedersen; Louise B Jørgensen; Stephane Hue; Yizi Yang; Jan Gerstoft; Terese L Katzenstein
Journal:  AIDS Res Hum Retroviruses       Date:  2007-01       Impact factor: 2.205

2.  Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

Authors:  Kersten K Koelsch; Lin Liu; Richard Haubrich; Susanne May; Diane Havlir; Huldrych F Günthard; Caroline C Ignacio; Paula Campos-Soto; Susan J Little; Robert Shafer; Gregory K Robbins; Richard T D'Aquila; Yuji Kawano; Karen Young; Phillip Dao; Celsa A Spina; Douglas D Richman; Joseph K Wong
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

3.  Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques.

Authors:  David A Hokey; F Brad Johnson; Jasmine Smith; Joshua L Weber; Jian Yan; Lauren Hirao; Jean D Boyer; Mark G Lewis; George Makedonas; Michael R Betts; David B Weiner
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

4.  Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.

Authors:  F Mercier; M-R Boulassel; B Yassine-Diab; C Tremblay; N-F Bernard; R-P Sekaly; J-P Routy
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

5.  Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.

Authors:  Sarah Palmer; Frank Maldarelli; Ann Wiegand; Barry Bernstein; George J Hanna; Scott C Brun; Dale J Kempf; John W Mellors; John M Coffin; Martin S King
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

6.  S-phase entry leads to cell death in circulating T cells from HIV-infected persons.

Authors:  Scott F Sieg; Douglas A Bazdar; Michael M Lederman
Journal:  J Leukoc Biol       Date:  2008-03-27       Impact factor: 4.962

7.  Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection.

Authors:  Julien van Grevenynghe; Francesco A Procopio; Zhong He; Nicolas Chomont; Catherine Riou; Yuwei Zhang; Sylvain Gimmig; Genevieve Boucher; Peter Wilkinson; Yu Shi; Bader Yassine-Diab; Elias A Said; Lydie Trautmann; Mohamed El Far; Robert S Balderas; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2008-03-02       Impact factor: 53.440

8.  Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells.

Authors:  Catherine Riou; Bader Yassine-Diab; Julien Van grevenynghe; Roland Somogyi; Larry D Greller; Dominic Gagnon; Sylvain Gimmig; Peter Wilkinson; Yu Shi; Mark J Cameron; Roberto Campos-Gonzalez; Robert S Balderas; David Kelvin; Rafick-Pierre Sekaly; Elias K Haddad
Journal:  J Exp Med       Date:  2006-12-26       Impact factor: 14.307

9.  Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.

Authors:  Ahmad R Sedaghat; Janet D Siliciano; Timothy P Brennan; Claus O Wilke; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2007-08-31       Impact factor: 6.823

10.  Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation.

Authors:  Sue-Jane Lin; Craig D Peacock; Kapil Bahl; Raymond M Welsh
Journal:  J Exp Med       Date:  2007-09-04       Impact factor: 14.307

View more
  914 in total

1.  HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.

Authors:  Helene Mens; Mary Kearney; Ann Wiegand; Wei Shao; Kristian Schønning; Jan Gerstoft; Niels Obel; Frank Maldarelli; John W Mellors; Thomas Benfield; John M Coffin
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.

Authors:  Fredrick H Omondi; Sandali Chandrarathna; Shariq Mujib; Chanson J Brumme; Steven W Jin; Hanwei Sudderuddin; Rachel L Miller; Asa Rahimi; Oliver Laeyendecker; Phil Bonner; Feng Yun Yue; Erika Benko; Colin M Kovacs; Mark A Brockman; Mario Ostrowski; Zabrina L Brumme
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.

Authors:  Thomas A Rasmussen; James McMahon; J Judy Chang; Jori Symons; Michael Roche; Ashanti Dantanarayana; Afam Okoye; Bonnie Hiener; Sarah Palmer; Wen Shi Lee; Stephen J Kent; Carrie Van Der Weyden; H Miles Prince; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2017-08-24       Impact factor: 4.177

Review 4.  Tissue issues: mucosal T-cell responses in HIV-1 infection.

Authors:  Barbara L Shacklett; April L Ferre; Brenna E Kiniry
Journal:  Curr Opin HIV AIDS       Date:  2019-03       Impact factor: 4.283

5.  Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells.

Authors:  Nitasha A Kumar; Renee M van der Sluis; Talia Mota; Rachel Pascoe; Vanessa A Evans; Sharon R Lewin; Paul U Cameron
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

6.  Viral latency and potential eradication of HIV-1.

Authors:  Kenneth A Matreyek; Ilker Oztop; Eric O Freed; Alan Engelman
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

Review 7.  Harnessing CD4⁺ T cell responses in HIV vaccine development.

Authors:  Hendrik Streeck; M Patricia D'Souza; Dan R Littman; Shane Crotty
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

8.  Effect of combination antiretroviral therapy on Chinese rhesus macaques of simian immunodeficiency virus infection.

Authors:  Binhua Ling; Linda Rogers; Ann-Marie Johnson; Michael Piatak; Jeffrey Lifson; Ronald S Veazey
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-08       Impact factor: 2.205

9.  Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.

Authors:  David Palesch; Steven E Bosinger; Maud Mavigner; James M Billingsley; Cameron Mattingly; Diane G Carnathan; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Guido Silvestri
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

10.  The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Authors:  Mireille Laforge; Ricardo Silvestre; Vasco Rodrigues; Julie Garibal; Laure Campillo-Gimenez; Shahul Mouhamad; Valérie Monceaux; Marie-Christine Cumont; Henintsoa Rabezanahary; Alain Pruvost; Anabela Cordeiro-da-Silva; Bruno Hurtrel; Guido Silvestri; Anna Senik; Jérôme Estaquier
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.